Publications by authors named "Philip Colangelo"

Claim this Profile
F
Food and Drug Administration Public Workshop Summary-Addressing Challenges in Inhaled Antifungal Drug Development.
Caroline J Jjingo, Shukal Bala, Ursula Waack, Mark Needles, Timothy J Bensman, Philip Colangelo

Clin Infect Dis· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Food and Drug Administration Public Workshop Summary-Development Considerations of Antifungal Drugs to Address Unmet Medical Need.
Yuliya Yasinskaya, Shukal Bala, Ursula Waack, Cheryl Dixon, Karen Higgins, Philip Colangelo

Clin Infect Dis· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Regulatory Review Approach for Evaluation of Micafungin for Treatment of Neonatal Candidiasis.
Gillian Taormina, Ramya Gopinath, Jason Moore, Yuliya Yasinskaya, Philip Colangelo

Clin Infect Dis· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Body Weight and Age on the Pharmacokinetics of Dihydroartemisinin: Food and Drug Administration Basis for Dose Determination of Artesunate for Injection in Pediatric Patients With Severe Malaria.
Eliford Kitabi, Timothy J Bensman, Justin C Earp, Dakshina M Chilukuri, Heidi Smith, Philip M Colangelo

Clin Infect Dis· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Hollow Fiber System Model in the Nonclinical Evaluation of Antituberculosis Drug Regimens.
Dakshina Chilukuri, Owen McMaster, Kimberly Bergman, Philip Colangelo, Kerry Snow

Clin Infect Dis· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Amoxicillin for postexposure inhalational anthrax in pediatrics: rationale for dosing recommendations.
John J Alexander, Philip M Colangelo, Charles K Cooper, Rosemary Roberts, William J Rodriguez

Pediatr Infect Dis J· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New era in drug interaction evaluation: US Food and Drug Administration update on CYP enzymes, transporters, and the guidance process.
Shiew-Mei Huang, John M Strong, Lei Zhang, Kellie S Reynolds, Srikanth Nallani, Philip Colangelo

J Clin Pharmacol· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis